251 related articles for article (PubMed ID: 30975725)
1. Association between pancreatic cancer and metformin use in patients with type 2 diabetes.
Lai SW; Tsai CH; Lin CL; Liao KF
Postgrad Med J; 2019 May; 95(1123):291. PubMed ID: 30975725
[No Abstract] [Full Text] [Related]
2. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
[TBL] [Abstract][Full Text] [Related]
3. Metformin: fifty-two not out.
Campbell IW
J Indian Med Assoc; 2009 Nov; 107(11):779-84. PubMed ID: 20469782
[No Abstract] [Full Text] [Related]
4. Metformin may improve the prognosis of patients with pancreatic cancer.
Zhang JW; Sun Q
Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
[TBL] [Abstract][Full Text] [Related]
5. Metformin.
Bailey CJ; Turner RC
N Engl J Med; 1996 Feb; 334(9):574-9. PubMed ID: 8569826
[No Abstract] [Full Text] [Related]
6. Metformin and Pancreatic Cancer Risk in Patients With Type 2 Diabetes.
Tseng CH
Pancreas; 2018 Oct; 47(9):e57-e59. PubMed ID: 30199488
[No Abstract] [Full Text] [Related]
7. [Metformin and type-2 diabetes mellitus].
Mata Cases M
Aten Primaria; 2008 Mar; 40(3):147-53. PubMed ID: 18373928
[No Abstract] [Full Text] [Related]
8. Role of metformin in type II diabetes.
Epstein S
Cleve Clin J Med; 1995; 62(5):278-9. PubMed ID: 7586481
[No Abstract] [Full Text] [Related]
9. Metformin: intrinsic vasculoprotective properties.
Wiernsperger NF
Diabetes Technol Ther; 2000; 2(2):259-72. PubMed ID: 11469268
[No Abstract] [Full Text] [Related]
10. Metformin: evidence-based versus rational pharmacotherapy.
Smits P; Tack CJ
Neth J Med; 2002 Jul; 60(6):228-30. PubMed ID: 12365465
[No Abstract] [Full Text] [Related]
11. Antidiabetic therapies affect risk of pancreatic cancer.
Li D; Yeung SC; Hassan MM; Konopleva M; Abbruzzese JL
Gastroenterology; 2009 Aug; 137(2):482-8. PubMed ID: 19375425
[TBL] [Abstract][Full Text] [Related]
12. Metformin: a biguanide.
Tanja JJ; Langlass TM
Diabetes Educ; 1995; 21(6):509-10, 513-4. PubMed ID: 8549253
[TBL] [Abstract][Full Text] [Related]
13. Metformin and pancreatic cancer: a clue requiring investigation.
Pollak M
Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829
[TBL] [Abstract][Full Text] [Related]
14. The mystery of metformin.
Spiering MJ
J Biol Chem; 2019 Apr; 294(17):6689-6691. PubMed ID: 31028160
[No Abstract] [Full Text] [Related]
15. A proof of concept, preliminary study to determine the effect of Yogasnas in controlling type 2 diabetes mellitus in newly detected subjects (when compared to metformin monotherapy).
Viswanathan V; Chacko PT; Lavanya M; Tilak P
J Assoc Physicians India; 2006 Dec; 54():965-6. PubMed ID: 17334022
[No Abstract] [Full Text] [Related]
16. Improving management of type 2 diabetes mellitus: 2. Biguanides.
Quillen DM; Samraj G; Kuritzky L
Hosp Pract (1995); 1999 Oct; 34(11):41-4. PubMed ID: 10887428
[No Abstract] [Full Text] [Related]
17. Metformin for cancer prevention.
Yang Y
Front Med; 2011 Jun; 5(2):115-7. PubMed ID: 21695613
[No Abstract] [Full Text] [Related]
18. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
19. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
[TBL] [Abstract][Full Text] [Related]
20. [Metformin role in the treatment of type 2 diabetes in 2008].
Spada A; Philippe J
Rev Med Suisse; 2008 Jun; 4(160):1392-4, 1396-7. PubMed ID: 18630062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]